HER2 Positive

Explore clinical trials studying HER2 Positive. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

HER2 Positive trial results

Not Yet Recruiting

T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

NCT07683754

Conditions: Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Dual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer

NCT07059338

Conditions: Colonic Diseases, Colorectal Cancer (CRC), Colorectal Neoplasms, +10 more
Locations: The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, China

View Trial Details

Not Yet Recruiting

Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer

NCT06818773

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +5 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

NCT01226316

Conditions: AKT1, Adnexal Diseases, Advanced Solid Malignancy, +46 more
Locations: Research Site Los Angeles, California, United States

Research Site Stanford, California, United States

Research Site West Hollywood, California, United States

Research Site Aurora, Colorado, United States

View all 34 locations

View Trial Details

Completed

Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer

NCT00614978

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +12 more
Locations: Jules Bordet Institute Brussels, Belgium

View Trial Details

Completed

Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study

NCT00768859

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Medisch Centrum Alkmaar Alkmaar, Netherlands

NKI-AVL Amsterdam, Netherlands

Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands

Reinier de Graaf Gasthuis Delft, Netherlands

View Trial Details

Active, Not Recruiting

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2

NCT01996267

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands

MCA Alkmaar, Netherlands

ZGT Almelo, Netherlands

Antoni van Leeuwenhoek Amsterdam, Netherlands

View all 33 locations

View Trial Details

HER2 Positive

HER2 Positive trial results

T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

Dual EGFR/HER2 Blockade Combined With Irinotecan for the Treatment of HER2-Positive Metastatic Colorectal Cancer

Inetetamab Plus Chemotherapy ± PD-1/PD-L1 in HER2+ Advanced Biliary Cancer

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer

Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2

Related conditions